Literature DB >> 7889565

Increased neutrophil respiratory burst in bcr-null mutants.

J W Voncken1, H van Schaick, V Kaartinen, K Deemer, T Coates, B Landing, P Pattengale, O Dorseuil, G M Bokoch, J Groffen.   

Abstract

Philadelphia (Ph)-positive leukemias invariably contain a chromosomal translocation fusing BCR to ABL. The BCR-ABL protein is responsible for leukemogenesis. Here we show that exposure of bcr-null mutant mice to gram-negative endotoxin led to severe septic shock and increased tissue injury by neutrophils. Neutrophils of bcr (-/-) mice showed a pronounced increase in reactive oxygen metabolite production upon activation and were more sensitive to priming stimuli. Activated (-/-) neutrophils displayed a 3-fold increased p21rac2 membrane translocation compared with (+/+) neutrophils. These results connect Bcr in vivo with the regulation of Rac-mediated superoxide production by the NADPH-oxidase system of leukocytes and suggest a link between Bcr function and the cell type affected in Ph-positive leukemia.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7889565     DOI: 10.1016/0092-8674(95)90350-x

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  36 in total

1.  High incidence of recurrent copy number variants in patients with isolated and syndromic Müllerian aplasia.

Authors:  Serena Nik-Zainal; Reiner Strick; Mekayla Storer; Ni Huang; Roland Rad; Lionel Willatt; Tomas Fitzgerald; Vicki Martin; Richard Sandford; Nigel P Carter; Andreas R Janecke; Stefan P Renner; Patricia G Oppelt; Peter Oppelt; Christine Schulze; Sara Brucker; Matthew Hurles; Matthias W Beckmann; Pamela L Strissel; Charles Shaw-Smith
Journal:  J Med Genet       Date:  2011-01-28       Impact factor: 6.318

2.  Opsonization modulates Rac-1 activation during cell entry by Leishmania amazonensis.

Authors:  J Morehead; I Coppens; N W Andrews
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  The Bcr kinase downregulates Ras signaling by phosphorylating AF-6 and binding to its PDZ domain.

Authors:  G Radziwill; R A Erdmann; U Margelisch; K Moelling
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

4.  Rho/RacGAPs: embarras de richesse?

Authors:  Roland Csépányi-Kömi; Magdolna Lévay; Erzsébet Ligeti
Journal:  Small GTPases       Date:  2012-07-01

5.  Abr and Bcr, two homologous Rac GTPase-activating proteins, control multiple cellular functions of murine macrophages.

Authors:  Young Jin Cho; Jess M Cunnick; Sun-Ju Yi; Vesa Kaartinen; John Groffen; Nora Heisterkamp
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

Review 6.  ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases.

Authors:  André Schmandke; Antonio Schmandke; Stephen M Strittmatter
Journal:  Neuroscientist       Date:  2007-10       Impact factor: 7.519

7.  Interactions between cytosolic components of the NADPH oxidase: p40phox interacts with both p67phox and p47phox.

Authors:  F B Wientjes; G Panayotou; E Reeves; A W Segal
Journal:  Biochem J       Date:  1996-08-01       Impact factor: 3.857

8.  Kaposi's sarcoma-associated herpesvirus microRNAs repress breakpoint cluster region protein expression, enhance Rac1 activity, and increase in vitro angiogenesis.

Authors:  Dhivya Ramalingam; Christine Happel; Joseph M Ziegelbauer
Journal:  J Virol       Date:  2015-01-28       Impact factor: 5.103

9.  Abr and Bcr are multifunctional regulators of the Rho GTP-binding protein family.

Authors:  T H Chuang; X Xu; V Kaartinen; N Heisterkamp; J Groffen; G M Bokoch
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

10.  Dynamic control of excitatory synapse development by a Rac1 GEF/GAP regulatory complex.

Authors:  Kyongmi Um; Sanyong Niu; Joseph G Duman; Jinxuan X Cheng; Yen-Kuei Tu; Brandon Schwechter; Feng Liu; Laura Hiles; Anjana S Narayanan; Ryan T Ash; Shalaka Mulherkar; Kannan Alpadi; Stelios M Smirnakis; Kimberley F Tolias
Journal:  Dev Cell       Date:  2014-06-23       Impact factor: 12.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.